Samsung Medical Center

Gangnam-gu, Seoul 135-710

1 studies enrolling now · 7 studies all time

What they study most

Acute Myeloid Leukemia, Breast Cancer, Colorectal Cancer, Diabetes Mellitus, Type 2, Endometrial Cancer, Esophageal Cancer, Gastric Cancer, Gastroesophageal Cancer, HER-2 Protein Overexpression, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors — Recruiting now
• TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers — Completed
• A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) — Stopped early
• A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus — Completed
• A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer — Completed
• Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML) — Completed
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer — Completed